Peroxisome proliferator-activated receptor gamma (PPAR-gamma): a novel therapeutic target for asthma? A randomised double blind placebo controlled clinical trial.

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

03 Dec 2015 Biomarkers information updated
07 Mar 2012 Actual end date 31 Jan 2012 added as reported by UKCRN.
07 Mar 2012 Status changed from recruiting to completed as reported by UKCRN.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com